dc.contributor.author | Endo, IC | en_US |
dc.contributor.author | Ziegelmann, PK | en_US |
dc.contributor.author | Patel, A | en_US |
dc.date.accessioned | 2016-10-31T10:59:56Z | |
dc.date.available | 2016-10-17 | en_US |
dc.date.issued | 2016-12-07 | en_US |
dc.date.submitted | 2016-10-18T08:18:44.054Z | |
dc.identifier.issn | 0264-410X | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/16164 | |
dc.format.extent | 6133 - 6147 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | VACCINE | en_US |
dc.rights | © 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.rights | This is a pre-copyedited, author-produced PDF of an article accepted for publication in Vaccine following peer review. The version of record is available http://www.sciencedirect.com/science/article/pii/S0264410X16309720 | |
dc.subject | Dengue | en_US |
dc.subject | Vaccine | en_US |
dc.subject | Cost-effectiveness | en_US |
dc.subject | Economic | en_US |
dc.subject | Quality assessment | en_US |
dc.title | The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review | en_US |
dc.type | Article | |
dc.rights.holder | (c) The Author(s) 2016. | |
dc.rights.holder | © 2016 Elsevier Ltd | |
dc.identifier.doi | 10.1016/j.vaccine.2016.10.037 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000390622600009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 50 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 34 | en_US |